Brackmann Christoph 4
4 · NovoCure Ltd · Filed Nov 4, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Brackmann Christoph
Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2025-11-04$12.23/sh−7,033$86,014→ 134,117 total
Footnotes (1)
- [F1]Represents the number of shares required to be withheld by the issuer to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This transaction is not discretionary and approved as required pursuant to Rules 16b-3(e) and 16b-3(d)(1).